Nuwellis Inc. to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
Interested parties can access a live webcast of the presentation directly by following this link. An archived webcast of the presentation will be available on the “Investors” section of the Nuwellis website at https://ir.nuwellis.com/ following the event.
Those parties interested in registering for the Inaugural Gilmartin Group Emerging Growth Company Showcase may do so by following this link.
About Nuwellis
About the Aquadex SmartFlow System
The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload). The Aquadex SmartFlow system is indicated for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a health care provider, within an outpatient or inpatient clinical setting, under physician prescription, both having received training in extracorporeal therapies.
Contact
INVESTORS:
Matt.bacso@gilmartinir.com
MEDIA:
Health+Commerce
260-336-6202
jstebing@healthandcommerce.com
Source: Nuwellis, Inc.
